Magazine Article | February 1, 2019

BeiGene Exec Talks Candidly About Quality, Compliance, And Outsourcing

Source: Life Science Leader

By Louis Garguilo, Chief Editor, Outsourced Pharma

It was time within our greater ruminations on China (see to speak directly with a quality executive at a drug developer and manufacturer based there. That’s now been accomplished via a discussion with Diana Francis, VP of quality and compliance for BeiGene.

BeiGene is a biopharma developing and commercializing cancer drugs for global markets. It has been dubbed as a potential “Genentech of China.” The company also has locations in the U.S., Australia, and Europe.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader